Low-Dose Abiraterone Regimen: Drug Monitoring Might Be the Key
- PMID: 30188788
- DOI: 10.1200/JCO.2018.79.3174
Low-Dose Abiraterone Regimen: Drug Monitoring Might Be the Key
Comment in
-
Reply to I.F. Tannock, P. Isaacsson Velho et al, M. Tiako Meyo et al, and F.J.S.H. Woei-A-Jin et al.J Clin Oncol. 2018 Oct 20;36(30):3064-3065. doi: 10.1200/JCO.2018.79.3190. Epub 2018 Sep 6. J Clin Oncol. 2018. PMID: 30188784 No abstract available.
-
Reply to I.F. Tannock, P. Isaacsson Velho et al, R.Z. Szmulewitz et al, M. Tiako Meyo et al, and F.J.S.H. Woei-A-Jin et al.J Clin Oncol. 2018 Oct 20;36(30):3065-3066. doi: 10.1200/JCO.2018.79.3208. Epub 2018 Sep 6. J Clin Oncol. 2018. PMID: 30188791 No abstract available.
Comment on
-
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer.J Clin Oncol. 2018 May 10;36(14):1389-1395. doi: 10.1200/JCO.2017.76.4381. Epub 2018 Mar 28. J Clin Oncol. 2018. PMID: 29590007 Free PMC article. Clinical Trial.
Similar articles
-
Dose Reduction May Jeopardize Efficacy of Abiraterone Acetate.J Clin Oncol. 2018 Oct 20;36(30):3062-3064. doi: 10.1200/JCO.2018.79.3182. Epub 2018 Sep 6. J Clin Oncol. 2018. PMID: 30188790 No abstract available.
-
Low-Dose Abiraterone With Food: Rebutting an Editorial.J Clin Oncol. 2018 Oct 20;36(30):3060-3061. doi: 10.1200/JCO.2018.79.3018. Epub 2018 Sep 6. J Clin Oncol. 2018. PMID: 30188785 No abstract available.
-
Low-Fat Abiraterone Food Effect Is of Great Consequence.J Clin Oncol. 2018 Oct 20;36(30):3058-3059. doi: 10.1200/JCO.2018.79.2358. Epub 2018 Sep 6. J Clin Oncol. 2018. PMID: 30188783 No abstract available.
-
[Use of abiraterone acetate in the treatment of patients with metastatic castration resistant prostate cancer and no prior chemotherapy: 3 case reports and literature review].Beijing Da Xue Xue Bao Yi Xue Ban. 2014 Aug 18;46(4):653-6. Beijing Da Xue Xue Bao Yi Xue Ban. 2014. PMID: 25131489 Review. Chinese.
-
Pre-chemotherapy abiraterone acetate. A proposal of a treatment algorithm in castration resistant prostate cancer.Actas Urol Esp. 2014 Jun;38(5):327-33. doi: 10.1016/j.acuro.2013.10.008. Epub 2013 Dec 15. Actas Urol Esp. 2014. PMID: 24342031 Review. English, Spanish.
Cited by
-
Dose optimization during drug development: whether and when to optimize.J Natl Cancer Inst. 2023 May 8;115(5):492-497. doi: 10.1093/jnci/djac232. J Natl Cancer Inst. 2023. PMID: 36534891 Free PMC article.
-
Feasibility and efficacy of therapeutic drug monitoring of abiraterone in metastatic castration resistant prostate cancer patients.Br J Cancer. 2025 Apr;132(7):635-642. doi: 10.1038/s41416-025-02954-1. Epub 2025 Feb 11. Br J Cancer. 2025. PMID: 39934337 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources